Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-02-12

Clinical Trial Update: Effect of EGDT on Hepatic Perfusion in Patients With Septic Shock

View source ↗

Summary

Update on a clinical trial evaluating whether Early Goal-Directed Therapy affects hepatic perfusion in patients with septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Early Goal-Directed Therapy (EGDT) (early goal-directed therapy)

Snippet

Sponsor: Zhongda Hospital | Conditions: Septic Shock | Status: UNKNOWN